Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Role of GTR on Healing Outcome & Quality of Life in Combined Endo Perio Lesions With Communication

NCT06643663 · tracked via the Priya Life Science India tracker
Phase
Not applicable
Started
2024-05-23
Last updated
2025-01-08

Condition(s) studied

Periapical DiseasesEndodontic Disease

Investigational drug(s) / intervention(s)

Endodontic Micro-Surgery

Endodontic Micro-Surgery: Surgery performed using ACM membrane and PRF plug in test group \& without membrane \& PRF in control group.

Study summary

The recovery of periapical defects linked to periodontal communication frequently yields less satisfactory results. Numerous studies and case reports have highlighted the notable success achieved through the application of guided tissue regeneration techniques. More recently, autologous platelet concentrate plug \& placental membrane have emerged as a treatment option for addressing such lesions. Nevertheless, there has been no study using PRF-Medium with ACM membrane on the healing of aforesaid lesion \& quality of life assessment.

Eligibility

Sex
ALL
Min age
16 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. Patients of age 16yrs and above. 2. Patients with apico-marginal defects and deep pocket upto apex of tooth. 3. Failed primary root canal treatment. 4. Presence of interproximal bone loss. 5. Negative response to vitality test. 6. ASA-1 or ASA- 2 according to the classification of the American Society of Anesthesiologists) Exclusion criteria: 1. Presence of vertical root fracture 2. Presence of root perforations 3. ASA-3 or ASA-4 according to the classification of the American Society of Anesthesiologists) 4. Presence of root resorption 5. Combined endodontic-periodontic lesions. 6. Pregnancy

Primary outcome measure(s)

  • Periapical healing assessment — Base line to 12 months
    Periapical healing comparison in 2 groups 2D radiographic healing by Rud et al and Molven et al criteria and 3D healing by modified PENN 3D Criteria. Healing will be categorised into complete, incomplete, uncertain, unsaisfactory.

Trial sites (1)

FacilityCityRegionStatus
Pgids Rohtak Haryāna India Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06643663 on ClinicalTrials.gov ↗ ← All trials in India